Beryllium copper alloy (2%) causes chronic beryllium disease

Journal of Occupational and Environmental Medicine

Volumn 41, Issue 4, 1999, Pages 304-308

  Balkissoon, R C ^a,b   Newman, L S ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERYLLIUM; PREDNISONE;

ADULT; ARTICLE; BERYLLIOSIS; CASE REPORT; CHRONIC LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DYSPNEA; HEALTH HAZARD; HUMAN; INDUSTRIAL WORKER; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL LUNG DISEASE; PATIENT EDUCATION; THORAX RADIOGRAPHY;

EID: 0032922841     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-199904000-00013     Document Type: Article

References (30)

1. Maier LA, Newman LS. Beryllium disease. In: Rom WN, ed. Environmental and Occupational Medicine, 3rd ed. Philadelphia: Lippincott-Raven; 1998:1021-1035.
2. Kreiss K, Mroz MM, Zhen B, Wiedemann H, Barna B. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med. 1997;54:605-612.
3. Kreiss K, Wasserman S, Mroz MM, Newman LS. Beryllium disease screening in the ceramics industry: blood lymphocyte test performance and exposure-disease relations. J Occup Med. 1993;35: 267-274.
4. Zielinsky JF. Seven year experience summaries of beryllium air pollution in a modern alloy foundry. In: Proceedings of the 13th International Congress on Occupational Health, July 25-29, 1960, New York, NY: US Executive Committee of the Thirteenth International Congress on Occupational Health; 1961:592-600.
5. Preuss O. Assessment of risk potential. In: Rossman MD, Preuss OP, Powers MB, eds. Beryllium: Biomedical and Environmental Aspects. Baltimore: Williams & Wilkins; 1991:263-273.
6. Daniloff EM, Lynch DA, Bartelson BB, et al. Observer variation and relationship of computed tomography to severity of beryllium disease. Am J Respir Crit Care Med. 1997;155:2047-2056.
7. Newman LS, Buschman DL, Newell JD Jr, Lynch DA. Beryllium disease: assessment with CT. Radiology. 1994;190:835-840.
8. Newman LS. Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect. 1996; 104(suppl 5):953-956.
9. Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol. 1991; 88:54-60.
10. Newman LS. Beryllium disease and sarcoidosis: clinical and laboratory links. Sarcoidosis. 1995;12:7-19.
11. Bobka CA, Stewart LA, Engelken GJ, Golitz LE, Newman LS. Comparison of in vivo and in vitro measures of beryllium sensitization. J Occup Environ Med. 1997;39:540-547.
12. Newman LS, Kreiss K, King TE Jr, Seay S, Campbell PA. Pathologic and immunologie alterations in early stages of beryllium disease: re-examination of disease definition and natural history [see comments]. Am Rev Respir Dis. 1989; 139:1479-1486.
13. NIOSH. National Occupational Hazard Survey: Volume III, Survey Analysis and Supplemental Tables. Washington, DC: US Government Printing Office; 1977. DHEW Publication No. (NIOSH) 78-114.
14. Stonehouse AJ, Zenezak S. Properties, production, processes, and applications. In: Rossman M POP, Powers MB, ed. Beryllium Biomedical and Environmental Aspects. Baltimore: Williams & Wilkins; 1991:27-55.
15. Leinfelder KF. An evaluation of casting alloys used for restorative procedures. J Am Dent Assoc. 1997;128:37-45.
16. Newman LS. Casting alloys [letter, comment]. J Am Dent Assoc. 1997;128:550.
17. International Agency for Research on Cancer (IARC). Beryllium, Cadmium, mercury and exposures in the glass manufacturing industry. IARC Monogr Eval Carcinog Risk Hum. 1993;58:41-117.
18. Sterner JH, Eisenbud M. Epidemiology of beryllium intoxication. Arch Ind Hyg Occup Med. 1951;4:123-151.
19. Hardy HL, Tabershaw IR. Delayed chemical pneumonitis occurring in workers exposed to beryllium compounds. J Ind Hyg Toxicol. 1946;28:197-211.
20. Cullen MR, Kominsky JR, Rossman MD, et al. Chronic beryllium disease in a precious metal refinery: clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am Rev Respir Dis. 1987;135:201-208.
21. 3. Am J Ind Med. 1996;30:16-25.
22. Newman LS, Kreiss K. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium. Am Rev Respir Dis. 1992;145:1212-1214.
23. Richeldi L, Kreiss K, Mroz MM, et al. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med. 1997;32:337-340.
24. Yoshida T, Shima S, Nagaoka K, et al. A study on the beryllium lymphocyte transformation test and the beryllium levels in working environment. Ind Health. 1997; 35:374-379.
25. Tepper LB, Hardy HL, Chamberlin RI. Toxicity of beryllium compounds. In: Browning E, ed. Elsevier Monographs on Toxic Agents. Amsterdam: Elsevier Publishing Company; 1961:150-153.
26. Lieben J, Dattoli JA, Israel HI. Probable berylliosis from beryllium alloys. Arch Environ Health. 1964;9:473-477.
27. Jackson AJ. Beryllium alloys. In: Vorwald AJ, ed. Pneumoconiosis. London: Harper and Brothers; 1950:10-29.
28. Sneddon IB. Berylliosis: a case report. Br Med J. 1955;1:1448-1450.
29. Hasejima N, Kobayashi H, Takezawa S, et al. Chronic beryllium disease after exposure to low-beryllium-content copper [in Japanese]. Nippon Kyobu Shikkan Gakkai Zasshi. 1995;1:33:1105-1110.
30. Kriebel D, Sprince NL, Eisen EA, Greaves IA. Pulmonary function in beryllium workers: assessment of exposure. Br J Ind Med. 1988;45:83-92.